Lb Pharmaceuticals (LBRX) Shares Issued (2026)
Lb Pharmaceuticals' quarterly Shares Issued came in at $100.0 million in Q1 2026.
Lb Pharmaceuticals has reported Shares Issued for 1 years, with the latest figure at $100.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $100.0 million; the trailing twelve-month figure through Mar 2026 stood at $100.0 million (changed N/A YoY), and the FY2025 full-year result was $247000.0, up 973.91% from the prior year.
- Shares Issued for Q1 2026 stood at $100.0 million.
- The five-year high for Shares Issued was $100.0 million in Q1 2026, with the low at $100.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | 100.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00 Mn |
| Mar 31, 2026 | 100.00 Mn |